Home Forums Other Specialities Gastroenterology Sessile serrated Polyps-Have they been under diagnosed?

Viewing 0 reply threads
  • Author
    Posts
    • #2468
      Anonymous
      Inactive

      Sessile Serrated Polyps at Screening Colonoscopy Have They Been Under Diagnosed? Am J Gastroenterol. 2014;109(11):1698-1704.

      Jill Tinmouth MD, PhD, Pauline Henry MD, PhD, Eugene Hsieh MDCM, Nancy N Baxter MD, PhD, Robert J Hilsden MD, PhD, S Elizabeth McGregor PhD, Lawrence F Paszat MD, MS, Arlinda Ruco MPH, Refik Saskin MSc, Andrew J Schell MD, Emina E Torlakovic MD, PhD, Linda Rabeneck MD, MPHDisclosures

      Objectives The sessile serrated adenoma/polyp (SSA/P) is increasingly recognized as an important precursor to colorectal cancer (CRC) and may contribute to proximal postcolonoscopy CRCs. Hyperplastic polyps (HPs) generally follow a more benign course than do SSA/Ps, but they have a similar histologic appearance. Our aims were to identify patient and polyp factors associated with reclassification of HPs as SSA/Ps during a central pathology review and to characterize and compare their subsequent clinical management with other polyps.

      Methods From 2003 to 2008, we prospectively enrolled asymptomatic persons aged 50–74 years in a study of screening colonoscopy. Because criteria for SSA/P diagnosis evolved over our study period, we initiated a second review of all HPs >5 mm in size in 2011, with reclassification of polyps if indicated. Rates of subsequent colonoscopies, polypectomies, and CRCs were identified.

      Results We enrolled 2,527 persons who underwent colonoscopy in whom 111 had HPs >5 mm. Thirty-two of the 111 participants (28.8%) with HPs >5 mm had their polyps reclassified as SSA/Ps. There were no significant differences in patient characteristics between those with reclassified SSA/Ps and those who had HPs >5 mm. SSA/Ps were more likely to be proximal (P<0.001) and larger (P<0.007) than the HPs. In all, 48.3% of those with high-risk adenomas received appropriate follow-up compared with 26.1% of those with high-risk SSA/Ps.

      Conclusions Almost 1/3 of recently diagnosed HPs >5 mm were reclassified as SSA/Ps. Patients previously diagnosed with larger HPs in the proximal colon may benefit from a pathologic review to ensure appropriate diagnosis and follow-up.

Viewing 0 reply threads
  • You must be logged in to reply to this topic.